Annual Secretarial Compliance Report for the year ended 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
A practicing company secretary conducted a secretarial audit of Indrayani Biotech Ltd for FY 2025-26 under SEBI LODR regulations. The company was found compliant with most statutory requirements, but 6 violations were identified with fines totaling Rs. 3,17,420. These included late submissions of financial results (4 instances), delayed filing of related party transactions (2-day delay), and a gap of over 3 months in appointing a compliance officer after the previous one resigned in June 2025. Four observations from the previous year's report (FY 2024-25) were all regularized. The company also noted it is currently conducting a partly paid-up rights issue for existing shareholders.
The repeated delays in financial reporting and compliance officer vacancy signal weak internal controls and governance practices. While fines were paid and prior violations closed, ongoing filing delays may concern investors about management efficiency. The company appears operationally active with its rights issue but needs to strengthen its compliance framework.